James S. Hanson G1 Therapeutics, Inc. (GTHX) insider trading activity

GTHX Quotes by TradingView

James S. Hanson is General Counsel of G1 Therapeutics, Inc.. Currently has a direct ownership of 41,087 shares of GTHX, which is worth approximately $293,772. The most recent transaction as insider was on Jan 05, 2023, when has been sold 729 shares (Common Stock) at a price of $5.41 per share, resulting in proceeds of $3,943. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 41.1K
0% 3M change
0% 12M change
Total Value Held $293,772

James S. Hanson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 05 2023
SELL
Open market or private sale
$3,943 $5.41 p/Share
729 Reduced 1.74%
41,087 Common Stock
Jan 04 2023
SELL
Open market or private sale
$9,145 $5.58 p/Share
1,639 Reduced 3.77%
41,816 Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
-
17,900 Added 29.17%
43,455 Common Stock
Jan 05 2022
SELL
Open market or private sale
$15,331 $10.61 p/Share
1,445 Reduced 5.35%
25,555 Common Stock
Jan 03 2022
BUY
Grant, award, or other acquisition
-
12,000 Added 30.77%
27,000 Common Stock
Jan 04 2021
BUY
Grant, award, or other acquisition
-
11,000 Added 42.31%
15,000 Common Stock

Also insider at

FTRE
Fortrea Holdings Inc.
General Counsel
JSH

James S. Hanson

General Counsel
Research Triangle Park, NC

Track Institutional and Insider Activities on GTHX

Follow G1 Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GTHX shares.

Notify only if

Insider Trading

Get notified when an G1 Therapeutics, Inc. insider buys or sells GTHX shares.

Notify only if

News

Receive news related to G1 Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GTHX